BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26122358)

  • 1. Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer.
    Scrimini S; Pons J; Agustí A; Clemente A; Sallán MC; Bauçà JM; Soriano JB; Cosio BG; Lopez M; Crespi C; Sauleda J
    Cancer Immunol Immunother; 2015 Oct; 64(10):1261-70. PubMed ID: 26122358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells.
    Scrimini S; Pons J; Agustí A; Soriano JB; Cosio BG; Torrecilla JA; Núñez B; Córdova R; Iglesias A; Jahn A; Crespi C; Sauleda J
    Respir Med; 2013 Dec; 107(12):1895-903. PubMed ID: 23993707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-Derived Suppressor Cells: Possible Link Between Chronic Obstrucive Pulmonary Disease and Lung Cancer.
    Scrimini S; Pons J; Sauleda J
    Arch Bronconeumol; 2016 Jan; 52(1):29-35. PubMed ID: 26321390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.
    Kalathil SG; Lugade AA; Pradhan V; Miller A; Parameswaran GI; Sethi S; Thanavala Y
    Am J Respir Crit Care Med; 2014 Jul; 190(1):40-50. PubMed ID: 24825462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.
    Zeng QL; Yang B; Sun HQ; Feng GH; Jin L; Zou ZS; Zhang Z; Zhang JY; Wang FS
    Mol Cells; 2014 Jan; 37(1):66-73. PubMed ID: 24552712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease.
    Deshane JS; Redden DT; Zeng M; Spell ML; Zmijewski JW; Anderson JT; Deshane RJ; Gaggar A; Siegal GP; Abraham E; Dransfield MT; Chaplin DD
    J Allergy Clin Immunol; 2015 Feb; 135(2):413-424.e15. PubMed ID: 25420684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients.
    Darcy CJ; Minigo G; Piera KA; Davis JS; McNeil YR; Chen Y; Volkheimer AD; Weinberg JB; Anstey NM; Woodberry T
    Crit Care; 2014 Aug; 18(4):R163. PubMed ID: 25084831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer.
    Feng PH; Lee KY; Chang YL; Chan YF; Kuo LW; Lin TY; Chung FT; Kuo CS; Yu CT; Lin SM; Wang CH; Chou CL; Huang CD; Kuo HP
    Am J Respir Crit Care Med; 2012 Nov; 186(10):1025-36. PubMed ID: 22955317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
    Höchst B; Schildberg FA; Sauerborn P; Gäbel YA; Gevensleben H; Goltz D; Heukamp LC; Türler A; Ballmaier M; Gieseke F; Müller I; Kalff J; Kurts C; Knolle PA; Diehl L
    J Hepatol; 2013 Sep; 59(3):528-35. PubMed ID: 23665041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.
    Zhang B; Wang Z; Wu L; Zhang M; Li W; Ding J; Zhu J; Wei H; Zhao K
    PLoS One; 2013; 8(2):e57114. PubMed ID: 23437326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD45
    Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
    Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proportion and function of peripheral myeloid-derived suppressor cells do not correlate with systemic inflammation in chronic obstructive pulmonary disease.
    Tan DB; Fernandez S; Price P; Moodley YP
    Hum Immunol; 2014 Jan; 75(1):5-9. PubMed ID: 24090682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
    Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
    Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
    Biton J; Ouakrim H; Dechartres A; Alifano M; Mansuet-Lupo A; Si H; Halpin R; Creasy T; Bantsimba-Malanda C; Arrondeau J; Goldwasser F; Boudou-Rouquette P; Fournel L; Roche N; Burgel PR; Goc J; Devi-Marulkar P; Germain C; Dieu-Nosjean MC; Cremer I; Herbst R; Damotte D
    Am J Respir Crit Care Med; 2018 Oct; 198(7):928-940. PubMed ID: 29518341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down regulation of T cell receptor expression in COPD pulmonary CD8 cells.
    Grundy S; Plumb J; Lea S; Kaur M; Ray D; Singh D
    PLoS One; 2013; 8(8):e71629. PubMed ID: 23977094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
    Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
    Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating myeloid-derived suppressor cells in patients with pancreatic cancer.
    Xu XD; Hu J; Wang M; Peng F; Tian R; Guo XJ; Xie Y; Qin RY
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):99-105. PubMed ID: 26818550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.